AAF
SRPT icon

Andra AP-fonden’s Sarepta Therapeutics SRPT Stock Holding History

Andra AP-fonden’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,300
Closed -$222K – 600
2020
Q4 		$222K Sell
1,300
-200
-13% -$29.6K ﹤0.01% 600
2020
Q3 		$211K Sell
1,500
-6,700
-82% -$1.02M 0.01% 615
2020
Q2 		$1.31M Sell
8,200
-6,800
-45% -$925K 0.04% 619
2020
Q1 		$1.47M Buy
+15,000
New +$1.71M 0.05% 632

Other funds holding SRPT

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Andra AP-fonden's SRPT Position: Q1 2021 in Review

Andra AP-fonden sold out of Sarepta Therapeutics (SRPT) in Q1 2021, closing a stake of 1,300 shares — an estimated $222K sold.

Andra AP-fonden first reported a position in SRPT in Q1 2020 and held it in 4 quarters. The position peaked at $1.47M in Q1 2020. 366 funds tracked by Wall St. Rank hold SRPT as of Q1 2021.

  • Andra AP-fonden reported no remaining Sarepta Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Andra AP-fonden sold 1,300 Sarepta Therapeutics shares in Q1 2021, an estimated $222K.
  • Andra AP-fonden first reported a position in Sarepta Therapeutics in Q1 2020 and held it in 4 quarters.
  • Andra AP-fonden's Sarepta Therapeutics position peaked at $1.47M in Q1 2020.
  • 366 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2021.

Based on Andra AP-fonden's 13F filing for Q1 2021, filed 17 May 2021.